907 related articles for article (PubMed ID: 15231172)
1. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
2. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
3. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
[TBL] [Abstract][Full Text] [Related]
4. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
5. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
6. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
Berini CA; Eirin ME; Pando MA; Biglione MM
J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
9. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
10. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
[TBL] [Abstract][Full Text] [Related]
12. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
Khabbaz RF; Onorato IM; Cannon RO; Hartley TM; Roberts B; Hosein B; Kaplan JE
N Engl J Med; 1992 Feb; 326(6):375-80. PubMed ID: 1729620
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
[TBL] [Abstract][Full Text] [Related]
15. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
16. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
17. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
[TBL] [Abstract][Full Text] [Related]
18. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Fawaz NA; Tamim H; Almawi WY
Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]